TARA
Protara Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.04 / 10
Netural
Money flow analysis registers 7.31/10, showing robust fund flow characteristics. Positive momentum in no significant trends is countered by negative tendencies in overall, block, Small, Medium, Large, and Extra-large, suggesting positive flow conditions. Professional analyst opinion suggests overwhelmingly bullish analyst consensus, showing strong conviction.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-07
InstitutionPiper Sandler
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of TARA?
- TARA holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.04/10 (Netural).
